<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2020.00123</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical Characteristics of Functional Movement Disorders in the Stomatognathic System</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yoshida</surname> <given-names>Kazuya</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/370362/overview"/>
</contrib>
</contrib-group>
<aff><institution>Department of Oral and Maxillofacial Surgery, National Hospital Organization, Kyoto Medical Center</institution>, <addr-line>Kyoto</addr-line>, <country>Japan</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Steven Frucht, Mount Sinai Hospital, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Alberto J. Espay, University of Cincinnati, United States; Pedro Ribeiro, Federal University of Rio de Janeiro, Brazil</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Kazuya Yoshida <email>yoshida.kazuya.ut&#x00040;mail.hosp.go.jp</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Movement Disorders, a section of the journal Frontiers in Neurology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>03</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>123</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>02</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2020 Yoshida.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Yoshida</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p><bold>Background:</bold> Functional (psychogenic) movement disorders often have distinguishable clinical features in the orofacial region. Tonic mandibular deviation accompanying ipsilateral downward and lateral lip pulling is the most common phenotype seen in patients with facial functional movement disorders. However, functional movement disorders in the stomatognathic system are underrecognized.</p>
<p><bold>Objective:</bold> This study aimed to evaluate clinical characteristics and phenomenology in patients with functional movement disorders in the stomatognathic system.</p>
<p><bold>Methods:</bold> Ten-item inclusion criteria (point range: 0&#x02013;10) for functional movement disorders in the stomatognathic system was produced, based on previously established criteria for functional movement disorders and general signs of functional facial dystonia, to determine subject inclusion. The criteria included inconsistency, incongruence, and paroxysm in symptoms; rapid onset; distractibility; suggestibility; static course; spreading to multiple sites; spontaneous remission; and lack of sensory tricks. Fifty-eight patients [42 women (72.4%), 16 men (27.6%); mean age: 46.2 years] scored over 7 points on the criteria and were included in further analyses. Characteristic features, including the pattern and site of abnormal movements, were assessed in clinical examination.</p>
<p><bold>Results:</bold> Frequent items in the scale were inconsistent symptoms (93.1%), incongruous symptoms (91.4%), spreading to multiple sites (89.7%), paroxysmal symptoms (86.2%), and lack of sensory tricks (81%). Sixty percent of patients exhibited a pattern resembling dystonia. Some patients had a combination of organic and functional disease. Common involuntary movements included jaw deviation (74.1%), jaw closing (50%), lip pulling (34.5%), and tongue movement (31%). A functional dystonia phenotype (unilateral lower lip pulling and jaw deviation) was observed in 26 patients (44.8%). Characteristic features of functional stomatognathic movement disorders were rapidly repeating mandibular (lateral or tapping) and tongue movements (27.6%), which fluctuated in speed and direction.</p>
<p><bold>Conclusion:</bold> In 58 patients with functional movement disorders in the stomatognathic system, the functional dystonia phenotype was observed in 44.8%. Furthermore, 27.6% of patients showed the most characteristic type of functional stomatognathic movement disorders: very fast repeated jaw and/or lingual movements.</p></abstract>
<kwd-group>
<kwd>functional (psychogenic) movement disorders</kwd>
<kwd>functional (psychogenic) dystonia</kwd>
<kwd>involuntary movement</kwd>
<kwd>stomatognathic system</kwd>
<kwd>lip</kwd>
<kwd>tongue</kwd>
<kwd>phenomenology</kwd>
<kwd>treatment</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="42"/>
<page-count count="10"/>
<word-count count="6456"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Functional (psychogenic) movement disorders are part of a spectrum of functional neurological disorders, which are among the most common causes of neurological disability (<xref ref-type="bibr" rid="B1">1</xref>). In recent years, the term &#x0201C;functional&#x0201D; has been used more frequently than &#x0201C;psychogenic&#x0201D; in medical literature (<xref ref-type="bibr" rid="B2">2</xref>). The diagnosis of functional movement disorders is challenging. It should rely not on the exclusion of organic diseases or the presence of psychological features, but on the observation of clinical features of the specific movement disorders (<xref ref-type="bibr" rid="B3">3</xref>&#x02013;<xref ref-type="bibr" rid="B6">6</xref>). The Diagnostic and Statistical Manual of Mental Disorders does not require the presence of a psychologic stressor as a criterion for diagnosis (<xref ref-type="bibr" rid="B7">7</xref>). Tremor, dystonia, myoclonus, and gait disturbance are the most prevalent presentations of functional movement disorders (<xref ref-type="bibr" rid="B3">3</xref>&#x02013;<xref ref-type="bibr" rid="B6">6</xref>), which may encompass 5&#x02013;20% of patients in a movement disorder clinic&#x02014;functional dystonia being one of the most common (<xref ref-type="bibr" rid="B8">8</xref>). Dystonia is characterized by sustained or task-specific muscle contractions that cause abnormal movements and/or postures (<xref ref-type="bibr" rid="B9">9</xref>). Diagnosis is based on the characteristic clinical features of focal dystonia, such as task-specificity, stereotypy, sensory tricks, morning benefit, co-contraction, and patients&#x00027; electromyographic findings (<xref ref-type="bibr" rid="B10">10</xref>&#x02013;<xref ref-type="bibr" rid="B13">13</xref>). Oromandibular dystonia is a focal dystonia that affects the masticatory, lower facial, and/or lingual muscles. It can be subdivided into jaw closing dystonia, jaw opening dystonia, lingual dystonia, jaw deviation dystonia, and jaw protrusion dystonia, or a combination of these subtypes (<xref ref-type="bibr" rid="B10">10</xref>&#x02013;<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>Functional facial movement disorders show tonic muscular spasms resembling dystonia, involving the lip, eyelids, perinasal region, and forehead (<xref ref-type="bibr" rid="B15">15</xref>&#x02013;<xref ref-type="bibr" rid="B18">18</xref>). The most common phenotype is tonic jaw deviation accompanying ipsilateral downward and lateral lip pulling, seen in 84.3% of patients with facial functional movement disorders involving the craniofacial region (<xref ref-type="bibr" rid="B15">15</xref>). Uni- or bilateral orbicularis oculi and platysma contraction are commonly associated (<xref ref-type="bibr" rid="B15">15</xref>). Functional movement disorders have rarely been considered from the standpoint of the stomatognathic system, which is an anatomic system comprising the jaws, tongue, lips, teeth, and associated soft tissues. Thus, functional movement disorders in this region are underrecognized. Misdiagnosis of oromandibular dystonia as temporomandibular disorders or a psychogenic disease is frequent. However, the situation in functional movement disorders in the stomatoganathic system must be more serious.</p>
<p>This study aimed to elucidate the phenomenological and clinical characteristics of functional movement disorders in the stomatognathic system.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<p>This is a retrospective study based on the clinical findings of the author in a single institution.</p>
</sec>
<sec sec-type="subjects" id="s3">
<title>Patients</title>
<p>One thousand seven hundred and twenty patients with complaints of involuntary movement or contracture of the masticatory, lingual, and/or lower facial muscles visited our department from 2007 to 2019. Structured interviews were carried out for each patient. Clinical features, all symptoms, and medical history were recorded in detail in the medical records. Involuntary movements and the change in symptoms were recorded on video at the first visit and every subsequent visit. Patients who were suspected to have inherited, degenerative, or other neurological diseases were referred to neurologists. Apparent organic diseases such as oromandibular dystonia, temporomandibular disorders, bruxism, dyskinesia, hemifacial spasm, multiple somatization, tremor, tic, myokymia, fibromyalgia, and chronic pain, were excluded from the analysis. Oromandibular dystonia was diagnosed according to the characteristic clinical features of focal dystonia such as stereotypy, task-specificity, sensory tricks, morning benefit, and patients&#x00027; electromyographic findings (<xref ref-type="bibr" rid="B10">10</xref>&#x02013;<xref ref-type="bibr" rid="B14">14</xref>). Temporomandibular disorders, bruxism, and dyskinesia were diagnosed as previously reported (<xref ref-type="bibr" rid="B13">13</xref>).</p>
</sec>
<sec id="s4">
<title>Inclusion Criteria for Functional Stomatognathic Movement Disorders</title>
<p>To comprehensively select patients with functional movement disorders in the stomatognathic system and minimize the false-positive errors, 10-item inclusion criteria were produced according to previously reported criteria for functional movement disorders (<xref ref-type="bibr" rid="B3">3</xref>&#x02013;<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B19">19</xref>&#x02013;<xref ref-type="bibr" rid="B22">22</xref>) or clinical characteristics in facial functional dystonia (<xref ref-type="bibr" rid="B15">15</xref>&#x02013;<xref ref-type="bibr" rid="B18">18</xref>). The criteria included 10 features (rapid onset, static course, paroxysmal symptoms, spreading to multiple sites, spontaneous remission, inconsistent symptoms, distractibility, incongruous symptoms, lack of sensory tricks, and suggestibility) (<xref ref-type="table" rid="T1">Table 1</xref>). Inconsistency was confirmed when movements varied over time or were changed or suppressed by complex tasks (<xref ref-type="bibr" rid="B4">4</xref>). Distractibility was evaluated using a finger-tapping movement at different speeds while counting serial-sevens backward. Incongruence was verified if movements were not present or progressed according to the phenotypic range of established organic movement disorders (<xref ref-type="bibr" rid="B4">4</xref>). Suggestibility was examined using a non-physiologic or placebo maneuver. Spontaneous remission was recorded during the follow-up period. If a patient had more than 7 out of 10 characteristics on the criteria, the patient was determined to have functional movement disorders.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Ten features of inclusion criteria.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th/>
<th valign="top" align="center"><bold><italic>N</italic></bold></th>
<th valign="top" align="center"><bold>%</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Rapid onset</td>
<td valign="top" align="center">43</td>
<td valign="top" align="center">74.1</td>
</tr>
<tr>
<td valign="top" align="left">Static course</td>
<td valign="top" align="center">35</td>
<td valign="top" align="center">60.3</td>
</tr>
<tr>
<td valign="top" align="left">Paroxysmal symptoms</td>
<td valign="top" align="center">50</td>
<td valign="top" align="center">86.2</td>
</tr>
<tr>
<td valign="top" align="left">Spreading to multiple sites</td>
<td valign="top" align="center">52</td>
<td valign="top" align="center">89.7</td>
</tr>
<tr>
<td valign="top" align="left">Spontaneous remission</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">58.6</td>
</tr>
<tr>
<td valign="top" align="left">Inconsistent symptoms</td>
<td valign="top" align="center">54</td>
<td valign="top" align="center">93.1</td>
</tr>
<tr>
<td valign="top" align="left">Distractibility</td>
<td valign="top" align="center">39</td>
<td valign="top" align="center">67.2</td>
</tr>
<tr>
<td valign="top" align="left">Incongruous symptoms</td>
<td valign="top" align="center">53</td>
<td valign="top" align="center">91.4</td>
</tr>
<tr>
<td valign="top" align="left">Lack of sensory tricks</td>
<td valign="top" align="center">47</td>
<td valign="top" align="center">81.0</td>
</tr>
<tr>
<td valign="top" align="left">Suggestibility</td>
<td valign="top" align="center">37</td>
<td valign="top" align="center">63.8</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s5">
<title>Diagnosis and Evaluation</title>
<p>After the exclusion of obvious organic disease, 157 patients (110 women and 47 men; mean age &#x000B1; standard deviation [SD]: 47.2 &#x000B1; 13.6 years) were evaluated using the rating scale. Fifty-eight patients (42 women and 16 men; mean age: 46.2 &#x000B1; 13.7 years) were diagnosed with having functional movement disorders after scoring over 7 points on the rating scale (<xref ref-type="table" rid="T1">Table 1</xref>). The demographic characteristics of the patients are shown in <xref ref-type="table" rid="T2">Table 2</xref>.</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Demographic characteristics of the patients.</p></caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<td valign="top" align="left">Number of patients [<italic>N</italic>]</td>
<td valign="top" align="left">58</td>
</tr>
<tr>
<td valign="top" align="left">Age (years) [mean (SD)]</td>
<td valign="top" align="left">46.2 (13.7)</td>
</tr>
<tr>
<td valign="top" align="left">Sex (women, men) [<italic>N</italic> (%)]</td>
<td valign="top" align="left">42 (72.4), 16 (27.6)</td>
</tr>
<tr>
<td valign="top" align="left">Duration of symptom (years) [mean (SD)]</td>
<td valign="top" align="left">4.1 (6.4)</td>
</tr>
<tr>
<td valign="top" align="left">Follow-up duration (months) [mean (SD)]</td>
<td valign="top" align="left">16.8 (29.1)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2"><bold>Chief complaints</bold> [<italic><bold>N</bold></italic> (%)]</td>
</tr>
<tr>
<td valign="top" align="left">Pain</td>
<td valign="top" align="left">29 (50.0)</td>
</tr>
<tr>
<td valign="top" align="left">Discomfort</td>
<td valign="top" align="left">19 (32.8)</td>
</tr>
<tr>
<td valign="top" align="left">Dysarthria</td>
<td valign="top" align="left">16 (27.6)</td>
</tr>
<tr>
<td valign="top" align="left">Esthetic problem</td>
<td valign="top" align="left">12 (20.7)</td>
</tr>
<tr>
<td valign="top" align="left">Masticatory disturbance</td>
<td valign="top" align="left">9 (15.5)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2"><bold>Patterns of involuntary movements</bold> [<italic><bold>N</bold></italic> (%)]</td>
</tr>
<tr>
<td valign="top" align="left">Jaw deviation</td>
<td valign="top" align="left">43 (74.1)</td>
</tr>
<tr>
<td valign="top" align="left">Jaw closing</td>
<td valign="top" align="left">29 (50.0)</td>
</tr>
<tr>
<td valign="top" align="left">Lip (pulling or deviation)</td>
<td valign="top" align="left">20 (34.5)</td>
</tr>
<tr>
<td valign="top" align="left">Tongue (protrusion or deviation)</td>
<td valign="top" align="left">18 (31.0)</td>
</tr>
<tr>
<td valign="top" align="left">Cervical (platysma or sternocleidmastoid)</td>
<td valign="top" align="left">17 (29.3)</td>
</tr>
<tr>
<td valign="top" align="left">Jaw opening</td>
<td valign="top" align="left">13 (22.4)</td>
</tr>
<tr>
<td valign="top" align="left">Around mouth</td>
<td valign="top" align="left">12(20.7)</td>
</tr>
<tr>
<td valign="top" align="left">Around eye</td>
<td valign="top" align="left">10 (17.2)</td>
</tr>
<tr>
<td valign="top" align="left">Facial</td>
<td valign="top" align="left">8 (13.8)</td>
</tr>
<tr>
<td valign="top" align="left">Tremor (lip or palate)</td>
<td valign="top" align="left">5 (8.6)</td>
</tr>
<tr>
<td valign="top" align="left">Jaw protrusion</td>
<td valign="top" align="left">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="left">7 (12.1)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2"><bold>Characteristic clinical features of organic dystonia</bold> [<italic><bold>N</bold></italic> (%)]</td>
</tr>
<tr>
<td valign="top" align="left">Stereotypy</td>
<td valign="top" align="left">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Task-specificity</td>
<td valign="top" align="left">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Sensory tricks</td>
<td valign="top" align="left">11 (19.0)</td>
</tr>
<tr>
<td valign="top" align="left"><italic>Intraoral sensory tricks</italic></td>
<td valign="top" align="left">11 (19.0)</td>
</tr>
<tr>
<td valign="top" align="left">Chewing gum</td>
<td valign="top" align="left">8 (13.8)</td>
</tr>
<tr>
<td valign="top" align="left">Foods</td>
<td valign="top" align="left">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Candy</td>
<td valign="top" align="left">1 (1.7)</td>
</tr>
<tr>
<td valign="top" align="left">Tissue paper</td>
<td valign="top" align="left">1 (1.7)</td>
</tr>
<tr>
<td valign="top" align="left">Gauze</td>
<td valign="top" align="left">1 (1.7)</td>
</tr>
<tr>
<td valign="top" align="left"><italic>Extraoral sensory tricks</italic></td>
<td valign="top" align="left">6 (10.3)</td>
</tr>
<tr>
<td valign="top" align="left">Finger</td>
<td valign="top" align="left">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Hand</td>
<td valign="top" align="left">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Morning benefit</td>
<td valign="top" align="left">10 (17.2)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2"><bold>Other dystonia</bold> [<italic><bold>N</bold></italic> (%)]</td>
</tr>
<tr>
<td valign="top" align="left">Cervical dystonia</td>
<td valign="top" align="left">12 (20.7)</td>
</tr>
<tr>
<td valign="top" align="left">Blepharospasm</td>
<td valign="top" align="left">9 (15.5)</td>
</tr>
<tr>
<td valign="top" align="left">Writer&#x00027;s cramp</td>
<td valign="top" align="left">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Upper limb</td>
<td valign="top" align="left">2 (3.4)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The pattern and site of abnormal movements, existence of clinical features of organic oromandibular dystonia, and other associated dystonia, were assessed in a clinical examination. The patients were asked for a history of consultations in medical departments and previous diagnoses, the existence of psychiatric diseases, and the duration of medication use. Abnormal jaw movements, including lateral shifts of the mandible, were recorded using Mandibular Kinesiograph (<xref ref-type="bibr" rid="B11">11</xref>) (K6 Diagnostic System, Myotronics Research Inc., Seattle, USA).</p>
</sec>
<sec id="s6">
<title>Treatments</title>
<p>The patients were treated according to each symptom by means of medication, muscle afferent block therapy (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>), botulinum toxin therapy (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>), mouth piece (sensory trick splint) (<xref ref-type="bibr" rid="B25">25</xref>), myomonitor (transcutaneous electro-neural stimulation) (<xref ref-type="bibr" rid="B25">25</xref>), and surgery (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). For mild cases, therapy with anticholinergic or antispasmodic agents, Chinese medicine or other relevant drugs was attempted. For patients with apparent muscle contractions, muscle afferent block therapy (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>) by injection of a local anesthetic (0.5% lidocaine, Xylocaine, Aspen Japan, Tokyo, Japan) was attempted on hyperactive muscles. In cases with favorable results, the treatment was continued. However, if the muscle afferent block was effective but the effect was transient, botulinum toxin therapy (Botox&#x000AE;, Allergan, Irvine, USA) was performed (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). If the muscle afferent block therapy showed unfavorable results, then following the patient&#x00027;s consent, they were referred to psychiatrists or acupuncturists. A myomonitor was applied for jaw closing muscle pain (<xref ref-type="bibr" rid="B25">25</xref>). Surgical procedures (coronoidotomy) were performed on patients with extremely limited mouth opening (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>), under general anesthesia. If these therapies resulted ineffective or gave unsatisfactory responses, sensory trick splints were applied (<xref ref-type="bibr" rid="B25">25</xref>). Subjective improvement was evaluated according to a linear self-rating scale ranging from 0 to 100% (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>).</p>
<p>This study was performed in accordance with the Declaration of Helsinki under the approval of the institutional review board and ethics committee of Kyoto Medical Center (09-37).</p>
</sec>
<sec sec-type="results" id="s7">
<title>Results</title>
<p><xref ref-type="table" rid="T1">Table 1</xref> indicates each of the 10 features of the inclusion criteria and their percentages. Frequent items in the scale were inconsistent symptoms (93.1%), incongruous symptoms (91.4%), spreading to multiple sites (89.7%), paroxysmal symptoms (86.2%), and lack of sensory tricks (81%).</p>
</sec>
<sec id="s8">
<title>Clinical Features of the Patients</title>
<p>The results of the analyzed involuntary movements are shown in <xref ref-type="table" rid="T2">Table 2</xref>. Approximately 60% of patients exhibited dystonia, resembling a pattern of involuntary movement. Other patients showed highly variable, incongruent, and inconsistent movements, which were similar to tremor, tic, and dyskinesia. However, it was impossible to classify them according to established movement disorders. Frequent patterns of involuntary movements included jaw deviation (74.1%), jaw closing (50%), lip pulling (34.5%), and tongue movement (31%) (<xref ref-type="table" rid="T2">Table 2</xref>). The classic phenotype (unilateral lip pulling and jaw deviation) was observed in 26 (44.8%) patients (22 women and 4 men; mean age 42.0 years) (<xref ref-type="fig" rid="F1">Figure 1</xref>). Characteristic features of functional stomatognathic movement disorders were repeated rapid mandibular (lateral or tapping) and/or tongue movements (<xref ref-type="fig" rid="F2">Figures 2</xref>, <xref ref-type="fig" rid="F3">3</xref>), which were observed in 13 patients (9 women and 4 men; mean age 48.5 years).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>The clinical presentation of functional stomatognathic movement disorders. A case with the well-known &#x0201C;classic&#x0201D; phenotype of orofacial functional dystonia. The patient shows unilateral lower lip pulling, jaw deviation, and platysma contraction (See also <xref ref-type="supplementary-material" rid="SM2">Video 1</xref>).</p></caption>
<graphic xlink:href="fneur-11-00123-g0001.tif"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>The most characteristic clinical features in functional stomatognathic movement disorders are rapidly repeated mandibular or lingual movements. The direction and speed of the movements occasionally fluctuate from lateral to vertical (See also <xref ref-type="supplementary-material" rid="SM3">Video 2</xref>).</p></caption>
<graphic xlink:href="fneur-11-00123-g0002.tif"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Tongue movement accompanying mandibular movement is complex and bizarre. It does not fall into any of the known movement disorders (See also <xref ref-type="supplementary-material" rid="SM4">Video 3</xref>).</p></caption>
<graphic xlink:href="fneur-11-00123-g0003.tif"/>
</fig>
<p>Some patients had a combination of organic and functional diseases. The clinical characteristic features of organic oromandibular dystonia are summarized in <xref ref-type="table" rid="T2">Table 2</xref>.</p>
</sec>
<sec id="s9">
<title>Past History of the Patients</title>
<p>Frequent precipitating events included dental treatments (44.8%) or physical trauma (12.1%) (<xref ref-type="table" rid="T3">Table 3</xref>). The average lag time between symptom onset and diagnosis of a functional movement disorder was 4.1 &#x000B1; 6.4 years. The patients had consulted a mean of 6.2 &#x000B1; 4.6 departments or hospitals (range: 2&#x02013;23). The visited departments included neurology (75.9%), dentistry (62.1%), oral and maxillofacial surgery (60.3%), psychiatry (55.2%), neurosurgery (36.2%), and acupuncture (29.3%) (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Past history of the patients.</p></caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<td valign="top" align="left" colspan="2"><bold>Precipitating events</bold> [<italic><bold>N</bold></italic> (%)]</td>
</tr>
<tr>
<td valign="top" align="left">Dental treatments</td>
<td valign="top" align="center">26 (44.8)</td>
</tr>
<tr>
<td valign="top" align="left">Tooth extraction</td>
<td valign="top" align="center">14 (24.1)</td>
</tr>
<tr>
<td valign="top" align="left">Bridge</td>
<td valign="top" align="center">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Crown</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Dental operation</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Implant treatment</td>
<td valign="top" align="center">1 (1.7)</td>
</tr>
<tr>
<td valign="top" align="left">Orthodontic treatment</td>
<td valign="top" align="center">1 (1.7)</td>
</tr>
<tr>
<td valign="top" align="left">Physical trauma</td>
<td valign="top" align="center">7 (12.1)</td>
</tr>
<tr>
<td valign="top" align="left">Trauma</td>
<td valign="top" align="center">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Operation</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Dislocation</td>
<td valign="top" align="center">1 (1.7)</td>
</tr>
<tr>
<td valign="top" align="left">Psychological stress</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Another disease</td>
<td valign="top" align="center">1 (1.7)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2"><bold>Visited departments or hospitals</bold> [<italic><bold>N</bold></italic> (%)]</td>
</tr>
<tr>
<td valign="top" align="left">Neurology</td>
<td valign="top" align="center">44 (75.9)</td>
</tr>
<tr>
<td valign="top" align="left">Dentistry</td>
<td valign="top" align="center">36 (62.1)</td>
</tr>
<tr>
<td valign="top" align="left">Oral and Maxillofacial Surgery</td>
<td valign="top" align="center">35 (60.3)</td>
</tr>
<tr>
<td valign="top" align="left">Psychiatry</td>
<td valign="top" align="center">32 (55.2)</td>
</tr>
<tr>
<td valign="top" align="left">Neurosurgery</td>
<td valign="top" align="center">21 (36.2)</td>
</tr>
<tr>
<td valign="top" align="left">Acupuncture</td>
<td valign="top" align="center">17 (29.3)</td>
</tr>
<tr>
<td valign="top" align="left">Otorhinolaryngology</td>
<td valign="top" align="center">12 (20.7)</td>
</tr>
<tr>
<td valign="top" align="left">Orthopedics</td>
<td valign="top" align="center">5 (8.6)</td>
</tr>
<tr>
<td valign="top" align="left">Pain clinic</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Internal medicine</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Rehabilitation</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Ophthalmology</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Chiropractic</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2"><bold>Previous diagnosis</bold> [<italic><bold>N</bold></italic> (%)]</td>
</tr>
<tr>
<td valign="top" align="left">Unknown etiology</td>
<td valign="top" align="center">45 (77.6)</td>
</tr>
<tr>
<td valign="top" align="left">Psychiatric disease</td>
<td valign="top" align="center">44 (75.9)</td>
</tr>
<tr>
<td valign="top" align="left">Temporomandibular disorders</td>
<td valign="top" align="center">26 (44.8)</td>
</tr>
<tr>
<td valign="top" align="left">Dyskinesia</td>
<td valign="top" align="center">21 (36.6)</td>
</tr>
<tr>
<td valign="top" align="left">Bruxism</td>
<td valign="top" align="center">20 (34.5)</td>
</tr>
<tr>
<td valign="top" align="left">Dystonia</td>
<td valign="top" align="center">16 (27.6)</td>
</tr>
<tr>
<td valign="top" align="left">Chronic pain</td>
<td valign="top" align="center">5 (8.6)</td>
</tr>
<tr>
<td valign="top" align="left">Functional dystonia</td>
<td valign="top" align="center">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Occlusal problem</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Trigeminal neuralgia</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Normal</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="center">6 (10.3)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Psychiatric medication</bold> [<italic>N</italic> (%)]</td>
<td valign="top" align="center">40 (69.0)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2"><bold>Diagnosis</bold> [<italic><bold>N</bold></italic> (%)]</td>
</tr>
<tr>
<td valign="top" align="left">Depression</td>
<td valign="top" align="center">23 (39.7)</td>
</tr>
<tr>
<td valign="top" align="left">Bipolar disorder</td>
<td valign="top" align="center">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Schizophrenia</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Panic disorder</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">PTSD</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="center">7 (12.1)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Duration of medication</bold> (years) [mean (SD)]</td>
<td valign="top" align="center">14.6 (6.5)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2"><bold>Prescribed medicine</bold> [<italic><bold>N</bold></italic> (%)]</td>
</tr>
<tr>
<td valign="top" align="left">Etizolam</td>
<td valign="top" align="center">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Aripiprazole</td>
<td valign="top" align="center">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Lorazepam</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Milnacipran</td>
<td valign="top" align="center">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Olanzapine</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Clotiazepam</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Bromazepam</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Lofrazepate</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Quetiapine</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Alprazolam</td>
<td valign="top" align="center">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="center">6 (10.3)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The patients were diagnosed with or suspected to have conditions of unknown etiology (77.6%), psychogenic disorders (75.9%), temporomandibular disorders (44.8%), bruxism (34.5%), dyskinesia (36.2%), and dystonia (27.6%) (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<p>Forty patients (69%) had taken psychiatric medication. In these patients, the mean duration of neuroleptic or tranquilizer use was 14.6 &#x000B1; 6.5 years (<xref ref-type="table" rid="T3">Table 3</xref>). Neuroleptic drugs or tranquilizers had been prescribed for depression (39.7%), bipolar disorder (6.9%), and schizophrenia (5.2%) (<xref ref-type="table" rid="T3">Table 3</xref>). The prescribed drugs included etizolam (6.9%), aripiprazole (6.9%), milnacipran (5.6%), lorazepam (5.2%), and mirtazapine (5.2%) (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
</sec>
<sec id="s10">
<title>Treatments</title>
<p>The results of the treatment methods are summarized in <xref ref-type="table" rid="T4">Table 4</xref>. The author prescribed baclofen, trihexyphenidyl, clonazepam, tiapride, zolpidem, or Chinese medicine to 34 patients (58.6%). The mean subjective improvement from pharmacotherapy was 15.9%. Botulinum toxin was injected 98 times (range: 1&#x02013;11 times, mean: 3.5 &#x000B1; 3.0 times) in 28 patients (48.3%) without significant complications. The injected muscles included the lateral pterygoid, masseter, genioglossus, posterior belly of the digastric, temporalis, risorius, and other muscles, depending on the symptoms of each patient (<xref ref-type="table" rid="T4">Table 4</xref>, <xref ref-type="fig" rid="F4">Figure 4</xref>). The mean subjective improvement from botulinum toxin injection was 45.2%. Muscle afferent block therapy was performed in 19 patients (32.8%) for a total of 47 times (range: 1&#x02013;10 times, mean: 2.5 &#x000B1; 2.7 times), with a mean subjective improvement of 20.6%. Sensory trick splints were made and inserted into the mandibular dental arch of 16 patients (27.6%). The splints were used during daytime and helpful to seven patients (12.1%), with a mean subjective improvement rate of 20.1%. A patient with severe restricted mouth opening underwent coronoidotomy, which resulted in an improvement of the condition. A myomonitor was applied in several patients with jaw elevator muscle pain and brought temporary amelioration of pain. Acupuncture was slightly effective in some patients.</p>
<table-wrap position="float" id="T4">
<label>Table 4</label>
<caption><p>Results of treatment methods.</p></caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<td valign="top" align="left"><bold>Pharmacotherapy</bold> [<italic>N</italic> (%)]</td>
<td valign="top" align="left">34 (58.6)</td>
</tr>
<tr>
<td valign="top" align="left">Baclofen</td>
<td valign="top" align="left">22 (37.9)</td>
</tr>
<tr>
<td valign="top" align="left">Trihexyphenidyl</td>
<td valign="top" align="left">15 (25.9)</td>
</tr>
<tr>
<td valign="top" align="left">Clonazepam</td>
<td valign="top" align="left">5 (8.6)</td>
</tr>
<tr>
<td valign="top" align="left">Chinese medicine</td>
<td valign="top" align="left">5 (8.6)</td>
</tr>
<tr>
<td valign="top" align="left">Tiapride</td>
<td valign="top" align="left">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Etizolam</td>
<td valign="top" align="left">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Zolpidem</td>
<td valign="top" align="left">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="left">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Muscle afferent block therapy</bold></td>
<td valign="top" align="left">19 (32.8)</td>
</tr>
<tr>
<td valign="top" align="left">Lateral pterygoid (inferior head)</td>
<td valign="top" align="left">13 (22.4)</td>
</tr>
<tr>
<td valign="top" align="left">Masseter</td>
<td valign="top" align="left">9 (15.5)</td>
</tr>
<tr>
<td valign="top" align="left">Genioglossus</td>
<td valign="top" align="left">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Digastric (posterior belly)</td>
<td valign="top" align="left">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Temporalis</td>
<td valign="top" align="left">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Risorius</td>
<td valign="top" align="left">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Platysma</td>
<td valign="top" align="left">1 (1.7)</td>
</tr>
<tr>
<td valign="top" align="left">Medial pterygoid</td>
<td valign="top" align="left">1 (1.7)</td>
</tr>
<tr>
<td valign="top" align="left">Trapezius</td>
<td valign="top" align="left">1 (1.7)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Botulinum toxin therapy</bold></td>
<td valign="top" align="left">28 (48.3)</td>
</tr>
<tr>
<td valign="top" align="left">Masseter</td>
<td valign="top" align="left">14 (24.1)</td>
</tr>
<tr>
<td valign="top" align="left">Lateral pterygoid (inferior head)</td>
<td valign="top" align="left">12 (20.7)</td>
</tr>
<tr>
<td valign="top" align="left">Temporalis</td>
<td valign="top" align="left">9 (15.5)</td>
</tr>
<tr>
<td valign="top" align="left">Medial pterygoid</td>
<td valign="top" align="left">5 (8.6)</td>
</tr>
<tr>
<td valign="top" align="left">Genioglossus</td>
<td valign="top" align="left">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Zygomatic major</td>
<td valign="top" align="left">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left">Risorius</td>
<td valign="top" align="left">3 (5.2)</td>
</tr>
<tr>
<td valign="top" align="left">Digastric (posterior belly)</td>
<td valign="top" align="left">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Platysma</td>
<td valign="top" align="left">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Trapezius</td>
<td valign="top" align="left">2 (3.4)</td>
</tr>
<tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="left">4 (6.9)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Sensory trick splint therapy</bold></td>
<td valign="top" align="left">16 (27.6)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Surgical therapy (coronoidotomy)</bold></td>
<td valign="top" align="left">1 (1.7)</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Effects of treatments. After botulinum toxin therapy was applied to the risorius and masseter muscles and platysma for the patient shown in <xref ref-type="fig" rid="F1">Figure 1</xref>, involuntary orofacial movements reduced (See also <xref ref-type="supplementary-material" rid="SM5">Video 4</xref>).</p></caption>
<graphic xlink:href="fneur-11-00123-g0004.tif"/>
</fig>
</sec>
<sec sec-type="discussion" id="s11">
<title>Discussion</title>
<p>This study is the first to evaluate the clinical and phenomenological characteristics of patients with functional movement disorders in the stomatognathic system. This retrospective study was based on the experience of one specialist in involuntary movements in the stomatognathic system at one institution. All patients were diagnosed, evaluated, treated, recorded, and followed-up by the same specialist. Thus, inconsistencies in the diagnosis and evaluation are minimal.</p>
</sec>
<sec id="s12">
<title>Diagnosis</title>
<p>Although there are neither specific electrophysiologic tests nor a gold standard for diagnosis, functional dystonia is diagnosed with clinically definite certainty based on available criteria, regardless of any psychiatric symptoms (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Fahn and Williams (<xref ref-type="bibr" rid="B19">19</xref>) introduced four categories of diagnostic certainty: documented, clinically established, probable, and possible. However, the categories of possible and probable functional dystonia are less helpful clinically and only the clinically definite level was suggested to be useful for diagnosis (<xref ref-type="bibr" rid="B28">28</xref>). Shill and Gerber (<xref ref-type="bibr" rid="B20">20</xref>) suggested revisions to the diagnostic criteria based on a laboratory-supported, clinically definite diagnostic category by means of electrophysiologic findings. Recently, Espay et al. (<xref ref-type="bibr" rid="B6">6</xref>) emphasized that a diagnosis will be able to be made in an inclusionary manner by identifying neurological features specific to functional neurological disorders without relying on the presence or absence of psychological stressors or historical clues.</p>
<p>Although authorities on functional movement disorders can differentially diagnose with clinically definite certainty, this is often difficult in the absence of typical clinical features. To comprehensively diagnose patients with functional stomatognathic movement disorders, the author used a rating scale with 10 inclusionary signs as inclusion criteria in this study. Because functional stomatognathic movement disorders can coexist with organic dystonia, dyskinesia, and bruxism in a relatively high number of patients, it was difficult to determine a cut-off point for the scale. The author set a strict inclusion limit (over 7 out of 10 points) to minimize false-positive diagnostic errors, and to evaluate clinical and phenomenological characteristics in clinically definite patients with functional stomatognathic movement disorders. A rating scale is required to confirm reliability and validity on the basis of a standard method for the health measurement scale (<xref ref-type="bibr" rid="B13">13</xref>). However, the main purpose of the rating scale described in this study was not to evaluate functional movement disorders, but to comprehensively select patients with this entity from patients with complaints of involuntary movement or contraction. Hence, properties such as internal consistency and test-retest reliability were not analyzed in the present study.</p>
<p>Oromandibular dystonia is often misdiagnosed as temporomandibular disorder, psychogenic disorder, or bruxism (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Movement disorders in the stomatognathic system constitute a blind spot between medical science and dentistry (<xref ref-type="bibr" rid="B13">13</xref>). Although infrequently, neurologists tend to diagnose temporomandibular disorder as oromandibular dystonia, i.e., bruxism as jaw closing dystonia, and internal derangement of temporomandibular joint as jaw deviation dystonia (<xref ref-type="bibr" rid="B13">13</xref>). Experience and knowledge of neurology and of dental or oral and maxillofacial surgery are needed to differentiate movement disorders in the stomatognathic system from temporomandibular disorders. Unfortunately, it is practically almost impossible to obtain them simultaneously. The author has treated patients with both involuntary movements and temporomandibular disorders for over 30 years at the departments of both oral and maxillofacial surgery and neurology. Nearly 90% of patients with oromandibular dystonia had either not been diagnosed or were suspected to have oromandibular dystonia (<xref ref-type="bibr" rid="B29">29</xref>). Although it is critical to diagnose patients immediately at the primary care level and refer them to appropriate experts, the patients visited 4.1 hospitals for 3.8 years to obtain a diagnosis of oromandibular dystonia (<xref ref-type="bibr" rid="B13">13</xref>). In this study, only 5.2% of patients had been suspected to have functional movement disorders. All of them had been diagnosed by experienced neurologists (movement disorder specialists). The patients in the present study visited 6.2 hospitals over 4.1 years. The vast majority of patients with functional stomatognathic movement disorders, who had symptoms solely or mainly in the stomatognathic system, tended to visit at first dentists or oral and maxillofacial surgeons. Frequent diagnoses included unknown etiology, temporomandibular disorders, bruxism, or psychiatric disease (<xref ref-type="table" rid="T3">Table 3</xref>). The patients were treated without improvement using dental procedures or referred to psychiatrists, leading to iatrogenic harm, unnecessary examinations, and poor outcomes. Patients often abandoned treatment or further consultation. The situation is much more serious in functional oromandibular dystonia than in its organic counterpart. Many patients with functional oromandibular dystonia are neither correctly recognized nor diagnosed. Healthcare workers should pay careful attention to functional stomatognathic movement disorders.</p>
</sec>
<sec id="s13">
<title>Phenomenology of Functional Stomatognathic Movement Disorders</title>
<p>The most prevalent chief complaint in this study was pain (50%), while a previous study reported 24.6% of cases complained of painful spasms (<xref ref-type="bibr" rid="B15">15</xref>). Dysarthria (27.6%) and masticatory disturbance (15.5%) were also more common in this study than in previous reports (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B17">17</xref>). This occurred likely because this study evaluated exclusively patients who had symptoms in the stomatognathic region. Depression was observed in 38% of patients in a previous study (<xref ref-type="bibr" rid="B15">15</xref>) and in 39.7% of patients in this study.</p>
<p>Frequent precipitating events were dental treatment (44.8%) and physical trauma (12.1%), while physiological stress was only present in 5.2% in this study. Dental treatments or orofacial trauma have been considered to precipitate the onset of oromandibular dystonia in predisposed individuals (<xref ref-type="bibr" rid="B30">30</xref>). Peripheral trauma has been associated with the onset of a wide range of movement disorders (<xref ref-type="bibr" rid="B31">31</xref>). Minor traumatic events, including dental treatment, might be associated with the occurrence of functional stomatognathic movement disorders.</p>
<p>Combined organic and functional movement disorders can coexist in the same patient. The most common phenotypes of functional facial movement disorders have been recognized as identifiable, such as unilateral lower lip and jaw deviation, or laterocollis with ipsilateral shoulder elevation and contralateral shoulder depression (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). On the other hand, the most characteristic regional phenotype in the stomatognathic system was rapidly repeated mandibular or lingual movements (<xref ref-type="fig" rid="F2">Figures 2</xref>, <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="supplementary-material" rid="SM3">Videos 2</xref>, <xref ref-type="supplementary-material" rid="SM4">3</xref>). The abnormal pattern fluctuates in severity, speed, and direction, differing from other organic movement disorders such as dystonia, dyskinesia, tremor, paroxysmal dyskinesia, and tic, not falling into any of the known movement disorders. The inconsistent and incongruent movement pattern agreed very well with functional movement disorders. The pattern was observed in 22.4% of patients.</p>
<p>Most previously reported cases were the classic phenotype of facial functional dystonia accompanying unilateral lip pulling, jaw deviation, and laterocollis (<xref ref-type="bibr" rid="B15">15</xref>&#x02013;<xref ref-type="bibr" rid="B18">18</xref>). In this study, 44.8% of patients exhibited this pattern. Fasano et al. (<xref ref-type="bibr" rid="B15">15</xref>) reported 84.3% of patients exhibited this phenotype in psychogenic facial movement disorders. In their study, women accounted for 91.8% of patients, with a mean age of 37 years. In the present study, 84.6% of patients were women and the mean age was 42 years in the 26 patients with the classic phenotype. Stone et al. reported that 81% of patients were women (<xref ref-type="bibr" rid="B18">18</xref>). In contrast, 72.4% of patients were women in this study. The patients were diagnosed based on the general features of functional dystonia, such as inconsistency and incongruency, using a rating scale as described previously. However, other types of functional movement disorders exist in the stomatognathic region. In a previous study across multiple specialized movement disorder centers, the classic phenotype has been advantageously selected from an enormous number of patients from the database (<xref ref-type="bibr" rid="B15">15</xref>). Other types of functional movement disorders in the orolingual region might have been excluded from the analysis. There are probably more patients with functional movement disorders that exhibit not only the well-known classic phenotype but also other types of functional stomatognathic movement disorders.</p>
<p>Sensory tricks are physical movements or positions that can temporarily interrupt dystonia. Patients may be aware of particular sensory tricks that relieve their symptoms. One of the characteristics of functional dystonia is the absence of a sensory trick (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B15">15</xref>), while it has been reported that 51.4% of patients with organic oromandibular dystonia had sensory tricks (<xref ref-type="bibr" rid="B13">13</xref>). In this study, 19% of patients had sensory tricks (<xref ref-type="table" rid="T2">Table 2</xref>). Morning benefit was observed in 17.2% of patients. Task-specificity and stereotypy were found in a few patients (<xref ref-type="table" rid="T2">Table 2</xref>). The clinical features of organic dystonia seem to partly overlap those of functional movement disorders.</p>
</sec>
<sec id="s14">
<title>Pathophysiology of Functional Stomatognathic Movement Disorders</title>
<p>The etiology of functional movement disorders is multifactorial (<xref ref-type="bibr" rid="B22">22</xref>). Gupta and Lang (<xref ref-type="bibr" rid="B21">21</xref>) introduced a laboratory-supported, definite diagnostic category according to electrophysiological findings in functional myoclonus and tremor. Electromyography and electroencephalography back-averaging were used for functional myoclonus. Frequency analysis of the electromyogram was applied to document distractibility or entrainment in functional tremor. Their neurophysiologic abnormalities in functional dystonia overlap considerably with those of organic counterparts, with similar abnormalities in somatosensory processing and cortical and spinal inhibition. However, emerging data suggest that there are impairments in regional blood flow and activation patterns on positron emission tomography and functional magnetic resonance imaging (<xref ref-type="bibr" rid="B32">32</xref>). Neurobiological abnormalities in functional neurological disorders include hypoactivation of the supplementary motor area and abnormal connectivity with areas that select or inhibit movements that are associated with a sense of agency (<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>We previously attempted to clarify the cortical neurophysiology related to mandibular movements and perception in the stomatognathic system, using electroencephalography (movement-related cortical potentials, contingent negative variation) (<xref ref-type="bibr" rid="B33">33</xref>&#x02013;<xref ref-type="bibr" rid="B37">37</xref>), magnetoencephalography (<xref ref-type="bibr" rid="B38">38</xref>&#x02013;<xref ref-type="bibr" rid="B40">40</xref>), and near-infrared spectroscopy (<xref ref-type="bibr" rid="B39">39</xref>). Because of artifacts arising from masticatory and/or facial activity and involuntary jaw movements, neuroimaging techniques are difficult in patients with involuntary movements in the orofacial region. A few studies have evaluated movement-related cortical potentials, including the Bereitschaftspotential and negative slope in oromandibular dystonia (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). Movement-related cortical potentials amplitude over central and parietal areas for jaw opening and lateral mandibular movements is significantly reduced compared to those in healthy subjects (<xref ref-type="bibr" rid="B35">35</xref>). In healthy controls, the movement-related cortical potentials at jaw opening and closing were symmetrically distributed. On the other hand, those of lateral movements showed a predominance in the hemisphere ipsilateral to the direction of the jaw movement (<xref ref-type="bibr" rid="B34">34</xref>)&#x02014;this laterality was not observed in the patient group. These results indicate that there is an abnormal cortical preparatory process for mandibular movements in oromandibular dystonia (<xref ref-type="bibr" rid="B35">35</xref>). To date, neurophysiologic studies on functional oromandibular dystonia have not been reported. Further studies are necessary to clarify the pathophysiology, neurophysiology, and etiology of the disorder.</p>
</sec>
<sec id="s15">
<title>Treatments for Functional Stomatognathic Movement Disorders</title>
<p>Treatment of functional movement disorders should begin with explaining the diagnosis and ensuring the patient&#x00027;s understanding of it (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B5">5</xref>). Treatments for functional dystonia include antidepressants, psychological therapy in the form of psychodynamic psychotherapy or cognitive behavior therapy, and transcranial magnetic stimulation (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B32">32</xref>). Generally, therapeutic effects were unsatisfactory in most cases in this study. Psychiatric treatments may have been required in some patients. However, very few psychiatrists or psychotherapists are willing to treat patients with functional movement disorders (<xref ref-type="bibr" rid="B41">41</xref>). When patients showed apparent muscle hyperactivity, botulinum toxin therapy helped considerably (<xref ref-type="fig" rid="F4">Figure 4</xref>, <xref ref-type="supplementary-material" rid="SM5">Video 4</xref>). The author applied muscle afferent block therapy to predict the effect of botulinum toxin therapy (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). For typical cases with jaw or tongue deviation, botulinum toxin should be administered to the lateral pterygoid muscle or tongue. As injection into the muscles can result in severe complications, careful injection based on the local anatomy is required (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Occlusal splints are effective for patients with a sensory trick in the oral cavity (<xref ref-type="bibr" rid="B25">25</xref>). As only 19% of patients had a sensory trick, the splints could relieve symptoms only for a limited amount of patients in this study. Favorable outcomes, including improvement just after muscle afferent block therapy (<xref ref-type="fig" rid="F2">Figures 2</xref>, <xref ref-type="fig" rid="F5">5</xref>, <xref ref-type="supplementary-material" rid="SM3">Videos 2</xref>, <xref ref-type="supplementary-material" rid="SM6">5</xref>), may be related to suggestibility or the placebo effect in functional movement disorders. The patients have been treated based on the author&#x00027;s experience without providing any level of evidence. Although the setting is clinically difficult, randomized control trials with a larger number of patients will be required to provide evidence of each treatment method. Further development of evidence-based therapeutic strategies is necessary. Furthermore, a multidisciplinary team approach, involving clinicians who can diagnose or treat functional stomatognathic dystonia (neurologist, psychiatrist, neurosurgeon, physiotherapist, psychotherapist, and oral surgeon) is preferable for the diagnosis of and tailored individual therapies for functional oromandibular dystonia.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Just after muscle afferent block (injection of 0.5% lidocaine) into the bilateral lateral pterygoid muscle for the patient in <xref ref-type="fig" rid="F2">Figure 2</xref>, rapid lateral jaw movements were completely suppressed (See also <xref ref-type="supplementary-material" rid="SM6">Video 5</xref>).</p></caption>
<graphic xlink:href="fneur-11-00123-g0005.tif"/>
</fig>
<p>The author&#x00027;s department specializes in oral and maxillofacial surgery. Therefore, the author solely examined the patients who exhibited symptoms in the stomatognathic system, including the lips, jaws, tongue, and lower face. The author has launched a website for patients with oromandibular dystonia &#x0201C;Involuntary movements of the stomatognathic region&#x0201D; (<xref ref-type="bibr" rid="B42">42</xref>), which has been accessed by many visitors from across the world (<xref ref-type="bibr" rid="B29">29</xref>). The population in the present report differs considerably from those in previous studies. Patients with hyperkinetic involuntary movements of the stomatognathic system were referred to our department from far away. Many patients who had already abandoned further consultation or treatment might have visited the author&#x00027;s department after informing themselves about involuntary movements of the stomatognathic region via the author&#x00027;s web site (<xref ref-type="bibr" rid="B29">29</xref>). At our department, we offer a wide range of multimodal therapies for involuntary movements, including medication, muscle afferent block, botulinum toxin injection, sensory trick splint, and surgery. The selection of subjects was clinic-based in the present study. Therefore, influence of referral bias cannot be excluded. Further studies involving a larger number of population-based samples are required to fully elucidate the clinical and phenomenological aspects of functional stomatognathic movement disorders.</p>
</sec>
<sec sec-type="conclusions" id="s16">
<title>Conclusion</title>
<p>Functional dystonia phenotype was observed in 44.8% of the 58 patients with functional movement disorders in the stomatognathic system included in this study. Furthermore, 27.6% of patients showed the most characteristic type of functional stomatognathic movement disorder: very fast repeated jaw and/or lingual movements.</p>
</sec>
<sec sec-type="data-availability-statement" id="s17">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.</p>
</sec>
<sec id="s18">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by Institutional Review Board and Ethics Committee of Kyoto Medical Center. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s19">
<title>Author Contributions</title>
<p>KY diagnosed and treated all patients, analyzed the results, and wrote the manuscript.</p>
<sec>
<title>Conflict of Interest</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<sec sec-type="supplementary-material" id="s20">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fneur.2020.00123/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fneur.2020.00123/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Video_1.MP4" id="SM2" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Video 1</label>
<caption><p>Note tonic lateral lip pulling, ipsilateral eye closure, and elevation of the contralateral eyebrow.</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Video_2.MP4" id="SM3" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Video 2</label>
<caption><p>Abnormal lateral jaw movement pattern. The movements fluctuate from lateral to vertical.</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Video_3.MPG" id="SM4" mimetype="video/mpeg" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Video 3</label>
<caption><p>Note the very fast tongue movement accompanying the mandibular movement. The movement is highly complex, bizarre, and does not fall into any established movement disorder category.</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Video_4.MP4" id="SM5" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Video 4</label>
<caption><p>Although the lateral cervical movement slightly remains, lip pulling has almost completely disappeared.</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Video_5.MP4" id="SM6" mimetype="video/mp4" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Video 5</label>
<caption><p>Rapidly repeated lateral jaw movement abolished just after muscle afferent block therapy of the bilateral lateral pterygoid muscles.</p></caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Carson</surname> <given-names>A</given-names></name> <name><surname>Lehn</surname> <given-names>A</given-names></name></person-group>. <source>Epidemiology.</source> In: <person-group person-group-type="editor"><name><surname>Hallett</surname> <given-names>M</given-names></name> <name><surname>Stone</surname> <given-names>J</given-names></name> <name><surname>Carson</surname> <given-names>A</given-names></name></person-group> editors. <italic>Handbook of Clinical Neurology, Vol. 139 (3rd series), Functional Neurologic Disorders.</italic> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2016</year>). p. <fpage>47</fpage>&#x02013;<lpage>60</lpage>.</citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname> <given-names>MJ</given-names></name> <name><surname>Stone</surname> <given-names>J</given-names></name> <name><surname>Lang</surname> <given-names>AE</given-names></name></person-group>. <article-title>From psychogenic movement disorder to functional movement disorder: it&#x00027;s time to change the name</article-title>. <source>Mov Disord.</source> (<year>2014</year>) <volume>29</volume>:<fpage>849</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1002/mds.25562</pub-id><pub-id pub-id-type="pmid">23843209</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morgante</surname> <given-names>F</given-names></name> <name><surname>Edwards</surname> <given-names>MJ</given-names></name> <name><surname>Espay</surname> <given-names>AJ</given-names></name></person-group>. <article-title>Psychogenic movement disorders</article-title>. <source>Continuum.</source> (<year>2013</year>) <volume>19</volume>:<fpage>1983</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1212/01.CON.0000436160.41071.79</pub-id><pub-id pub-id-type="pmid">24092294</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Espay</surname> <given-names>AJ</given-names></name> <name><surname>Lang</surname> <given-names>AE</given-names></name></person-group>. <article-title>Phenotype-specific diagnosis of functional (psychogenic) movement disorders</article-title>. <source>Curr Neurol Neurosci Rep.</source> (<year>2015</year>) <volume>15</volume>:<fpage>32</fpage>. <pub-id pub-id-type="doi">10.1007/s11910-015-0556-y</pub-id><pub-id pub-id-type="pmid">25900093</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Gasca-Salas</surname> <given-names>C</given-names></name> <name><surname>Lang</surname> <given-names>AE</given-names></name></person-group>. <article-title>Neurogenic diagnostic criteria for functional neurogenic disorders</article-title>. In: <person-group person-group-type="editor"><name><surname>Hallett</surname> <given-names>M</given-names></name> <name><surname>Stone</surname> <given-names>J</given-names></name> <name><surname>Carson</surname> <given-names>A</given-names></name></person-group> editors. <source>Handbook of Clinical Neurology, Vol. 139 (3rd series), Functional Neurologic Disorders.</source> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2016</year>). p. <fpage>193</fpage>&#x02013;<lpage>212</lpage>.</citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Espay</surname> <given-names>AJ</given-names></name> <name><surname>Aybek</surname> <given-names>S</given-names></name> <name><surname>Carson</surname> <given-names>A</given-names></name> <name><surname>Edwards</surname> <given-names>MJ</given-names></name> <name><surname>Goldstein</surname> <given-names>LH</given-names></name> <name><surname>Hallett</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Current concepts in diagnosis and treatment of functional neurological disorders</article-title>. <source>JAMA Neurol.</source> (<year>2018</year>) <volume>75</volume>:<fpage>1132</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2018.1264</pub-id><pub-id pub-id-type="pmid">29868890</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group>. <source>Diagnostic and Statistical Manual of Mental Diseases.</source> <edition>5th ed</edition>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychaiatric Association</publisher-name> (<year>2013</year>).</citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyasaki</surname> <given-names>JM</given-names></name> <name><surname>Sa</surname> <given-names>DS</given-names></name> <name><surname>Galvez-Jimenez</surname> <given-names>N</given-names></name> <name><surname>Lang</surname> <given-names>AE</given-names></name></person-group>. <article-title>Psychogenic movement disorders</article-title>. <source>Can J Neurol Sci.</source> (<year>2003</year>) <volume>30</volume>(<supplement>Suppl. 1</supplement>):<fpage>S94</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1017/S0317167100003292</pub-id><pub-id pub-id-type="pmid">12691482</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albanese</surname> <given-names>A</given-names></name> <name><surname>Bhatia</surname> <given-names>K</given-names></name> <name><surname>Bressman</surname> <given-names>SB</given-names></name> <name><surname>Delong</surname> <given-names>MR</given-names></name> <name><surname>Fahn</surname> <given-names>S</given-names></name> <name><surname>Fung</surname> <given-names>VS</given-names></name> <etal/></person-group>. <article-title>Phenomenology and classification of dystonia: a consensus up date</article-title>. <source>Mov Disord.</source> (<year>2013</year>) <volume>28</volume>:<fpage>863</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1002/mds.25475</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name> <name><surname>Kaji</surname> <given-names>R</given-names></name> <name><surname>Kubori</surname> <given-names>T</given-names></name> <name><surname>Kohara</surname> <given-names>N</given-names></name> <name><surname>Iizuka</surname> <given-names>T</given-names></name> <name><surname>Kimura</surname> <given-names>J</given-names></name></person-group>. <article-title>Muscle afferent block for the treatment of oromandibular dystonia</article-title>. <source>Mov Disord.</source> (<year>1998</year>) <volume>13</volume>:<fpage>699</fpage>&#x02013;<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1002/mds.870130416</pub-id><pub-id pub-id-type="pmid">9686778</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name> <name><surname>Kaji</surname> <given-names>R</given-names></name> <name><surname>Shibasaki</surname> <given-names>H</given-names></name> <name><surname>Iizuka</surname> <given-names>T</given-names></name></person-group>. <article-title>Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology</article-title>. <source>Int J Oral Maxillofac Surg.</source> (<year>2002</year>) <volume>31</volume>:<fpage>499</fpage>&#x02013;<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1054/ijom.2002.0291</pub-id><pub-id pub-id-type="pmid">12418565</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group>. <article-title>Clinical and phenomelogical characteristics of patients with task-specific lingual dystonia: possible association with occupation</article-title>. <source>Front Neurol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>649</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2017.00649</pub-id><pub-id pub-id-type="pmid">29321757</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group>. <article-title>Oromandibular dystonia screening questionnaire for differential diagnosis</article-title>. <source>Clin Oral Invest.</source> (<year>2019</year>) <volume>23</volume>:<fpage>405</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1007/s00784-018-2449-3</pub-id><pub-id pub-id-type="pmid">29717363</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group>. <article-title>Botulinum neurotoxin therapy for lingual dystonia using an individualized injection method based on clinical features</article-title>. <source>Toxins.</source> (<year>2019</year>) <volume>11</volume>:<fpage>51</fpage>. <pub-id pub-id-type="doi">10.3390/toxins11010051</pub-id><pub-id pub-id-type="pmid">30658420</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fasano</surname> <given-names>A</given-names></name> <name><surname>Valadas</surname> <given-names>A</given-names></name> <name><surname>Bhatia</surname> <given-names>KP</given-names></name> <name><surname>Prashanth</surname> <given-names>LK</given-names></name> <name><surname>Lang</surname> <given-names>AE</given-names></name> <name><surname>Munhoz</surname> <given-names>RP</given-names></name> <etal/></person-group>. <article-title>Psychogenic facial movement disorders: clinical features and associated conditions</article-title>. <source>Mov Disord.</source> (<year>2012</year>) <volume>27</volume>:<fpage>1544</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1002/mds.25190</pub-id><pub-id pub-id-type="pmid">23033125</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaski</surname> <given-names>D</given-names></name> <name><surname>Bronstein</surname> <given-names>AM</given-names></name> <name><surname>Edwards</surname> <given-names>MJ</given-names></name> <name><surname>Stone</surname> <given-names>J</given-names></name></person-group>. <article-title>Cranial functional (psychogenic) movement disorders</article-title>. <source>Lancet Neurol.</source> (<year>2015</year>) <volume>14</volume>:<fpage>1196</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(15)00226-4</pub-id><pub-id pub-id-type="pmid">26581970</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Fasano</surname> <given-names>F</given-names></name> <name><surname>Tinazzi</surname> <given-names>M</given-names></name></person-group>. <article-title>Functional facial and tongue movement disorders</article-title>. In: <person-group person-group-type="editor"><name><surname>Hallett</surname> <given-names>M</given-names></name> <name><surname>Stone</surname> <given-names>J</given-names></name> <name><surname>Carson</surname> <given-names>A</given-names></name></person-group> editors. <source>Handbook of Clinical Neurology, Vol. 139 (3rd series), Functional Neurologic Disorders.</source> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2016</year>). p. <fpage>353</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">27719855</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname> <given-names>J</given-names></name> <name><surname>Hoeritzauer</surname> <given-names>I</given-names></name> <name><surname>Tesolin</surname> <given-names>L</given-names></name> <name><surname>Carson</surname> <given-names>A</given-names></name></person-group>. <article-title>Functional movement disorders of the face: a historical review and case series</article-title>. <source>J Neurolog Sci.</source> (<year>2018</year>) <volume>395</volume>:<fpage>35</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2018.09.031</pub-id><pub-id pub-id-type="pmid">30286314</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fahn</surname> <given-names>S</given-names></name> <name><surname>Williams</surname> <given-names>DT</given-names></name></person-group>. <article-title>Psychogenic dystonia</article-title>. <source>Adv Neurol.</source> (<year>1988</year>) <volume>50</volume>:<fpage>431</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">3400501</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shill</surname> <given-names>H</given-names></name> <name><surname>Gerber</surname> <given-names>P</given-names></name></person-group>. <article-title>Evaluation of clinical diagnostic criteria for psychogenic movement disorders</article-title>. <source>Mov Disord.</source> (<year>2006</year>) <volume>21</volume>:<fpage>1163</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/mds.20921</pub-id><pub-id pub-id-type="pmid">16685685</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>A</given-names></name> <name><surname>Lang</surname> <given-names>AE</given-names></name></person-group>. <article-title>Psychogenic movement disorders</article-title>. <source>Curr Opin Neurol.</source> (<year>2009</year>) <volume>22</volume>:<fpage>430</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0b013e32832dc169</pub-id><pub-id pub-id-type="pmid">19542886</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hallett</surname> <given-names>M</given-names></name></person-group>. <article-title>Functional (psychogenic) movement disorders - clinical presentations</article-title>. <source>Parkinsonism Relat Disord.</source> (<year>2016</year>) <volume>22</volume>:<fpage>S149</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2015.08.036</pub-id><pub-id pub-id-type="pmid">26365778</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group>. <article-title>How do I inject botulinum toxin into the lateral and medial pterygoid muscles?</article-title> <source>Mov Disord Clin Pract.</source> (<year>2017</year>) <volume>4</volume>:<fpage>285</fpage>. <pub-id pub-id-type="doi">10.1002/mdc3.12460</pub-id><pub-id pub-id-type="pmid">30838273</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group>. <article-title>Computer-aided design/computer-aided manufacturing-derived needle guide for injection of botulinum toxin into the lateral pterygoid muscle in patients with oromandibular dystonia</article-title>. <source>J Oral Facial Pain Headache.</source> (<year>2018</year>) <volume>32</volume>:<fpage>e13</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.11607/ofph.1955</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group>. <article-title>Sensory trick splint as a multimodal therapy for oromandibular dystonia</article-title>. <source>J Prosthodont Res.</source> (<year>2018</year>) <volume>62</volume>:<fpage>239</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpor.2017.09.004</pub-id><pub-id pub-id-type="pmid">29126810</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group>. <article-title>Coronoidotomy as treatment for trismus due to jaw-closing oromandibular dystonia</article-title>. <source>Mov Disord.</source> (<year>2006</year>) <volume>21</volume>:<fpage>1028</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/mds.20859</pub-id><pub-id pub-id-type="pmid">16552755</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group>. <article-title>Surgical intervention for oromandibular dystonia-related limited mouth opening: long-term follow-up</article-title>. <source>J Craniomaxillofac Surg.</source> (<year>2017</year>) <volume>45</volume>:<fpage>56</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcms.2016.10.009</pub-id><pub-id pub-id-type="pmid">27908709</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morgante</surname> <given-names>F</given-names></name> <name><surname>Edwards</surname> <given-names>MJ</given-names></name> <name><surname>Espay</surname> <given-names>AJ</given-names></name> <name><surname>Fasano</surname> <given-names>A</given-names></name> <name><surname>Mir</surname> <given-names>P</given-names></name> <name><surname>Martino</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>Diagnostic agreement in patients with psychogenic movement disorders</article-title>. <source>Mov Disord.</source> (<year>2012</year>) <volume>27</volume>:<fpage>548</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1002/mds.24903</pub-id><pub-id pub-id-type="pmid">22488862</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group>. <article-title>Multilingual website and cyberconsultations for oromandibular dystonia</article-title>. <source>Neurol Int.</source> (<year>2018</year>) <volume>10</volume>:<fpage>7536</fpage>. <pub-id pub-id-type="doi">10.4081/ni.2018.7536</pub-id><pub-id pub-id-type="pmid">29844890</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sankhla</surname> <given-names>C</given-names></name> <name><surname>Lai</surname> <given-names>EC</given-names></name> <name><surname>Jankovic</surname> <given-names>J</given-names></name></person-group>. <article-title>Peripherally induced oromandibular dystonia</article-title>. <source>J Neurol Neurosurg Psychiatry.</source> (<year>1998</year>) <volume>65</volume>:<fpage>722</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.65.5.722</pub-id><pub-id pub-id-type="pmid">9810945</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawley</surname> <given-names>JS</given-names></name> <name><surname>Weiner</surname> <given-names>WJ</given-names></name></person-group>. <article-title>Psychogenic dystonia and peripheral trauma</article-title>. <source>Neurolog</source>y. (<year>2011</year>) <volume>77</volume>:<fpage>496</fpage>&#x02013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3182287aaf</pub-id><pub-id pub-id-type="pmid">21810699</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Schmerler</surname> <given-names>DA</given-names></name> <name><surname>Espay</surname> <given-names>AJ</given-names></name></person-group>. <article-title>Functional dystonia</article-title>. In: <person-group person-group-type="editor"><name><surname>Hallett</surname> <given-names>M</given-names></name> <name><surname>Stone</surname> <given-names>J</given-names></name> <name><surname>Carson</surname> <given-names>A</given-names></name></person-group> editors. <source>Handbook of Clinical Neurology, Vol. 139 (3rd series), Functional Neurologic Disorders.</source> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name> (<year>2016</year>). p. <fpage>235</fpage>&#x02013;<lpage>45</lpage>.</citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name> <name><surname>Kaji</surname> <given-names>R</given-names></name> <name><surname>Hamano</surname> <given-names>T</given-names></name> <name><surname>Kohara</surname> <given-names>N</given-names></name> <name><surname>Kimura</surname> <given-names>J</given-names></name> <name><surname>Iizuka</surname> <given-names>T</given-names></name></person-group>. <article-title>Cortical distribution of Bereitschafts potential and negative slope potential preceding mouth opening movements in human subjects</article-title>. <source>Arch Oral Biol.</source> (<year>1999</year>) <volume>44</volume>:<fpage>183</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/S0003-9969(98)00122-8</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name> <name><surname>Kaji</surname> <given-names>R</given-names></name> <name><surname>Hamano</surname> <given-names>T</given-names></name> <name><surname>Kohara</surname> <given-names>N</given-names></name> <name><surname>Kimura</surname> <given-names>J</given-names></name> <name><surname>Shibasaki</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Cortical potentials associated with voluntary mandibular movements</article-title>. <source>J Dent Res.</source> (<year>2000</year>) <volume>79</volume>:<fpage>1514</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1177/00220345000790071401</pub-id><pub-id pub-id-type="pmid">11005737</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name> <name><surname>Kaji</surname> <given-names>R</given-names></name> <name><surname>Kohara</surname> <given-names>N</given-names></name> <name><surname>Murase</surname> <given-names>N</given-names></name> <name><surname>Ikeda</surname> <given-names>A</given-names></name> <name><surname>Shibasaki</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Movement-related cortical potentials before jaw excursions in patients with oromandibular dystonia</article-title>. <source>Mov Disord.</source> (<year>2003</year>) <volume>18</volume>:<fpage>94</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1002/mds.10296</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name> <name><surname>Iizuka</surname> <given-names>T</given-names></name></person-group>. <article-title>Jaw-deviation dystonia evaluated by movement-related cortical potentials and treated with muscle afferent block</article-title>. <source>Cranio.</source> (<year>2003</year>) <volume>21</volume>:<fpage>295</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1080/08869634.2003.11746265</pub-id><pub-id pub-id-type="pmid">14620703</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name> <name><surname>Iizuka</surname> <given-names>T</given-names></name></person-group>. <article-title>Contingent negative variation elicited before jaw and tongue movements</article-title>. <source>J Oral Rehabil.</source> (<year>2005</year>) <volume>32</volume>:<fpage>871</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2842.2005.01450.x</pub-id><pub-id pub-id-type="pmid">16297033</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name> <name><surname>Maezawa</surname> <given-names>H</given-names></name> <name><surname>Nagamine</surname> <given-names>T</given-names></name> <name><surname>Fukuyama</surname> <given-names>H</given-names></name> <name><surname>Murakami</surname> <given-names>K</given-names></name> <name><surname>Iizuka</surname> <given-names>T</given-names></name></person-group>. <article-title>Somatosensory evoked magnetic fields to air-puff on the soft palate</article-title>. <source>Neurosci Res.</source> (<year>2006</year>) <volume>5</volume>:<fpage>116</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2006.02.007</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name> <name><surname>Suzuki</surname> <given-names>K</given-names></name> <name><surname>Shirai</surname> <given-names>Y</given-names></name> <name><surname>J</surname> <given-names>Ono</given-names></name></person-group>. <article-title>Brain activity in oromandibular dystonia assessed by near-infrared spectroscopy</article-title>. <source>J Dent Res.</source> (<year>2010</year>) <volume>89</volume>:<fpage>2787</fpage>.</citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maezawa</surname> <given-names>H</given-names></name> <name><surname>Yoshida</surname> <given-names>K</given-names></name> <name><surname>Matsuhashi</surname> <given-names>M</given-names></name> <name><surname>Yokoyama</surname> <given-names>Y</given-names></name> <name><surname>Mima</surname> <given-names>T</given-names></name> <name><surname>Bessho</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Evaluation of tongue sensory disturbance by somatosensory evoked magnetic fields following tongue stimulation</article-title>. <source>Neurosci Res.</source> (<year>2011</year>) <volume>71</volume>:<fpage>244</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2011.07.1831</pub-id><pub-id pub-id-type="pmid">21821071</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hallett</surname> <given-names>M</given-names></name></person-group>. <article-title>Functional movement disorders: is the crisis resolved?</article-title> <source>Mov Disord.</source> (<year>2019</year>) <volume>34</volume>:<fpage>971</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/mds.27713</pub-id><pub-id pub-id-type="pmid">31077443</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Yoshida</surname> <given-names>K</given-names></name></person-group>. <source>Involuntary Movements of the Stomatognathic Region.</source> (<year>2019</year>) Availabl eonline at: <ext-link ext-link-type="uri" xlink:href="https://sites.google.com/site/oromandibulardystoniaenglish/">https://sites.google.com/site/oromandibulardystoniaenglish/</ext-link> (accessed February 21, 2020).</citation></ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This study was supported by grants from the Japanese Ministry of Health, Labor, and Welfare (24592946, 22111201, and 19K102370001).</p>
</fn>
</fn-group>
</back>
</article>